However, NUDT21 was identified to be a tumor suppressor in human cervical cancer (22), bladder cancer (23), lung cancer (including small cell lung cancer and non-small cell lung cancer) (24–26), breast cancer (16, 27, 28), and hepatocellular carcinoma (15, 29, 30). This evidence concerns the gene NUDT21 and urinary bladder carcinoma.